MarketGrowthReport

Healthcare RFID Market Radiofrequency identification (RFID) is used for patient monitoring, efficiencies in patient care, tracking, and provider satisfaction. RFID is a wireless system that exploits radio waves for collecting data from a tag attached to an object, for several purposes such as automatic identification, and tracking of objects. The Healthcare RFID Market is expected to reach USD 1.89 billion by 2030 at 13.10% CAGR during the forecast period 2023-2030. Additionally, aggressive strategies adopted by the top players and the introduction of new products in the market are fueling the growth of the market during the forecast period. For instance, Alien Technology Corporation, a leader in RFID technology introduced RFID Reader with the ALR-F800-X, the product is known for its use in maintaining the workflow and efficiently handling the data. Also, the company is trying to expand its geographical boundaries by signing distribution agreements. The high costs associated...

Pedicle Screw Systems Market Pedicle screw systems market is expected to reach USD 771.18 Million at CAGR of 6.05 % during the forecast period of 2022 to 2030. Pedicle screw system are used in spinal surgery to stop the pain caused by joints owing to disease. The placement of the pedicle screw is independent of the laminar integrity and extends its application to a different level of spinal pathologies such as degenerative, oncological, degenerative and deformity correction. The increasing incidences of spinal cord injuries, spinal deformities, degenerative spinal disorders, and rising geriatric population are the major factors driving the growth of the global pedicle screw system market. Additionally, increasing research and development spending by the top players are fueling the growth of the market during forecast period. For instance, according to report published by Iranian Journal of  Neurosurgery, in 2016, prevalence of traumatic spinal cord injuries in Tehran ranged ...

Cancer API Market The Cancer API Market is expected to reach USD 1,48,545.23 Million by 2030 at 7.10% CAGR during the forecast period 2022-2030 , reveals Market Research Future (MRFR) in a minutely analyzed research report. Various factors are influencing the growth of the global cancer API market. Surging demand for small molecule drugs is one of the preliminary factors boosting the growth of the market. The small molecule API market is undergoing a period of rapid change. Small molecules are predominating the pharmaceutical industry and account for nearly 80% of the pharmaceutical sales, indicating their relevance in the future of pharmaceuticals. Moreover, small molecules have made significant development in the field of cancer treatment. Moreover, a growing trend of outsourcing has been witnessed in the manufacture of APIs which is expected to contribute to the market growth positively. The growth of the pharmaceutical industry in the developing countries is expected to prov...

Delirium Market The Delirium Market is expected to reach USD 365.7 Million by 2030 at 5.70% CAGR during the forecast period 2022-2030. Delirium is a neurological (nervous system) condition and is a serious disturbance in mental abilities that causes mental confusion and emotional disruption. Delirium can be caused due to various factors such as older age, exposure to certain medications, alcohol abuse, surgery or other medical procedures, factors such as exposure to toxic or infectious agents, physical trauma, diet, and behavioral and occupational factors. Major Key Players: Some of Delirium Market Players are Dr. Franz Kohler Chemie GmbH, Fraser Health, Gaia BioPharma Ltd., Novartis AG, Pfizer, Inc., Regenstrief Institute, Inc., and Air Liquide Sante International, among others. Segment Analysis The global delirium market is segmented on the basis of type, treatment, diagnosis, and end-user. On the basis of type, the market is segmented into hyperactive, hypoactive, ...

Myasthenia Gravis Disease Market The surging cases of neuromuscular disorders are estimated to favor the market growth globally. Myasthenia gravis is referred to as a neuromuscular disorder which results in the skeletal muscles to weaken. The Myasthenia Gravis Disease Market is projected to reach USD 1.9 Billion by 2030 at 7.70% CAGR during the forecast period 2022-2030. The disease generally occurs due to the impairment of communication between the nerve cells and the muscles and causes difficulty in the relaxation and contraction of muscles. The antibodies present in the body destroy the receptor for acetylcholine at the neuromuscular joint which prevents the muscles from contracting and performing its normal function. Major Key Players: Leading Myasthenia Gravis Disease Market Players are Fresenius Kabi, GSK plc, AbbVie Inc., Biogen Inc., Bristol-Myers Squibb Co., F. Hoffman-La Roche Ltd., Cipla, RPG Life Sciences, Teva Pharmaceutical Industries Ltd., Apotex Corporation,...

Acute Coronary Syndrome Market The escalating stress levels have caused a sharp spike in the number of cases detected in relation to heart diseases. Market reports connected with the healthcare industry have been made accessible by Market Research Future who publishes reports on other sectors that have been currently published along with a report on this industry. Acute Coronary Syndrome Market is projected to develop with a CAGR of 5.3% in the forecast period. Factors such as increased consumption of food that is saturated with fat, smoking, alcohol consumption and increasing prevalence of sedentary lifestyle are accredited with the rise in the cases of acute coronary syndrome cases in the forecast period. Growing research and development in the market is expected to reinforce the market expansion in the forecast period positively. Major Key Players: The some of Acute Coronary Syndrome Market Players are Johnson & Johnson Services, Inc. (U.S.), Teva Pharmaceutical Ind...

Bone Metastasis Market The increasing prevalence of breast cancer, growing geriatric population, rising healthcare expenditures, and increasing R&D expenses by the key players are estimated to drive the market growth during the forecast period. The Bone Metastasis Market is expected to reach USD 17.34 Billion by 2030 at 9.30% CAGR during the forecast period 2022-2030 Bone metastasis is a condition that occurs when cancerous cells from a non-bone site travel, i.e. metastasize, to bones. The spine, particularly the lower spine, the pelvis, and the thighs, are the most common sites for bone metastases. Bone metastasis can cause urinary and bowel incontinence, due to it being located quite close to both the urinary bladder and the rectal column, as well as hypercalcemia. While all cancers can manifest in this way, breast and prostate cancers are the likeliest sources of bone metastasis – 65-75% of patients suffering from breast or prostate cancers experience bone metastasis. The...